FDA panel recommends pulling Makena, citing ineffectiveness of controversial preterm birth dru - 1br
  • last year
The FDA advisory panel, made up of gynecologists, obstetricians and other fetal medicine experts, voted 14-1 to withdraw Makena from the market.

VIEW MORE : https://bit.ly/1breakingnews